{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:13:45Z","timestamp":1791252825629,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s12664-016-0657-9","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T02:48:07Z","timestamp":1463366887000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases"],"prefix":"10.1007","volume":"35","author":[{"given":"Vankadari","family":"Kousik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Promila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,16]]},"reference":[{"key":"657_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/jhep.2002.36807","volume":"36","author":"HB El-Serag","year":"2002","unstructured":"El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36:74\u201383.","journal-title":"Hepatology"},{"key":"657_CR2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-158-2-201301150-00574","volume":"158","author":"R Chou","year":"2013","unstructured":"Chou R, Cottrell EB, Wasson N, Rahman B, Guise JM. Screening for hepatitis C virus infection in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013;158:101\u20138.","journal-title":"Ann Intern Med"},{"key":"657_CR3","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/01.RVI.0000236744.34720.73","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3\u2014comprehensive literature review and future direction. J Vasc Interv Radiol. 2006;17:1571\u201393.","journal-title":"J Vasc Interv Radiol"},{"key":"657_CR4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.RVI.0000142602.79459.90","volume":"16","author":"JE Goin","year":"2005","unstructured":"Goin JE, Salem R, Carr BI, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol. 2005;16:195\u2013203.","journal-title":"J Vasc Interv Radiol"},{"key":"657_CR5","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ijrobp.2008.10.005","volume":"74","author":"AS Kennedy","year":"2009","unstructured":"Kennedy AS, McNeillie P, Dezarn WA, et al. Treatment parameters and outcome in 680 treatments of internal radiation with resin (90) Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys. 2009;74:1494\u2013500.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"657_CR6","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1088\/0031-9155\/53\/20\/008","volume":"53","author":"D Minarik","year":"2008","unstructured":"Minarik D, Sjogreen GK, Ljungberg M. Evaluation of quantitative 90Y SPECT based on experimental phantom studies. Phys Med Biol. 2008;53:5689\u2013703.","journal-title":"Phys Med Biol"},{"key":"657_CR7","doi-asserted-by":"crossref","unstructured":"Nickles RJ, Roberts AD, Nye JA, et al. Assaying and PET imaging of yttrium-90: 1.34 ppm.0. Conf Record of IEEE Nuclear Science Symp and Medical Imaging Conf. 2004; 3412\u20134.","DOI":"10.1109\/NSSMIC.2004.1466619"},{"key":"657_CR8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jvir.2007.02.002","volume":"18","author":"R Murthy","year":"2007","unstructured":"Murthy R, Brown DB, Salem R, et al. Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol. 2007;18:553\u201362.","journal-title":"J Vasc Interv Radiol"},{"key":"657_CR9","first-page":"168","volume":"55","author":"C Chiesa","year":"2011","unstructured":"Chiesa C, Maccauro M, Romito R, et al. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with Y-90 microspheres: the experience of the National Cancer Institute of Milan. Am J Nucl Med Mol Imaging. 2011;55:168\u201397.","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"657_CR10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026174","volume":"6","author":"M Elschot","year":"2011","unstructured":"Elschot M, Nijsen JF, Dam AJ, de Jong HW. Quantitative evaluation of scintillation camera imaging characteristics of isotopes used in liver radioembolization. PLoS One. 2011;6, e26174.","journal-title":"PLoS One"},{"key":"657_CR11","first-page":"S293","volume":"37","author":"L Elmbt","year":"2010","unstructured":"Elmbt L, Walrand S, Lhommel R, Jamar F, Pauwels S. Quantitative comparison between LYSO and BGO PET-tomographs in 90Y imaging. Eur J Nucl Med Mol Imaging. 2010;37:S293.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"657_CR12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.142.3.7063703","volume":"142","author":"RV Mantravadi","year":"1982","unstructured":"Mantravadi RV, Spigos DG, Tan WS, et al. Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology. 1982;142:783\u20136.","journal-title":"Radiology"},{"key":"657_CR13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF02586901","volume":"22","author":"ED Grady","year":"1979","unstructured":"Grady ED. Internal radiation therapy of hepatic cancer. Dis Colon Rectum. 1979;22:371\u20135.","journal-title":"Dis Colon Rectum"},{"key":"657_CR14","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/hep.22747","volume":"49","author":"A Riaz","year":"2009","unstructured":"Riaz A, Kulik L, Lewandowski RJ, et al. Radiologic pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology. 2009;49:1185\u201393.","journal-title":"Hepatology"},{"key":"657_CR15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2214\/AJR.06.0707","volume":"188","author":"FH Miller","year":"2007","unstructured":"Miller FH, Keppke AL, Reddy D, et al. Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET. AJR Am J Roentgenol. 2007;188:776\u201383.","journal-title":"AJR Am J Roentgenol"},{"key":"657_CR16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00432-013-1564-4","volume":"140","author":"A Saxena","year":"2014","unstructured":"Saxena A, Bester L, Shan L, et al. A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases. J Cancer Res Clin Oncol. 2014;140:537\u201347.","journal-title":"J Cancer Res Clin Oncol"},{"key":"657_CR17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1245\/s10434-013-3436-1","volume":"21","author":"A Saxena","year":"2014","unstructured":"Saxena A, Kapoor J, Meteling B, et al. Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients. Ann Surg Oncol. 2014;21:1296\u2013303.","journal-title":"Ann Surg Oncol"},{"key":"657_CR18","first-page":"49","volume":"3","author":"JE Goin","year":"2004","unstructured":"Goin JE, Dancey JE, Roberts CA, Sickles CJ, Leung DA, Soulen MC. Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: transcatheter arterial chemo-embolization versus yttrium-90 glass microspheres. World J Nuc Med. 2004;3:49\u201356.","journal-title":"World J Nuc Med"},{"key":"657_CR19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378\u201390.","journal-title":"N Engl J Med"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-016-0657-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-016-0657-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-016-0657-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T14:20:50Z","timestamp":1748960450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-016-0657-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["657"],"URL":"https:\/\/doi.org\/10.1007\/s12664-016-0657-9","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}